News

AstraZeneca Pushes COVID-19 Vaccine Candidate Forward

AstraZeneca Pushes COVID-19 Vaccine Candidate Forward

AstraZeneca has partnered with the University of Oxford in hopes of producing a viable coronavirus vaccine candidate. Phase I clinical trial data is expected to be promising, though further trials around the world will be needed. With 21 strategically located global depots, Yourway is positioned to move trial supplies around the world within hours.

Back to Index
Media

Upcoming Event

IQPC CTS

August 24-26, 2020
Brussels, Belgium

Media

Articles

The New Normal in Clinical Trial Protection

Open chat
Come chat with us!
Hello! How can I help you?